Dear Friends,
This community should be proud of the role we have played over the last several weeks preparing for the potential approval of multiple therapies to treat Duchenne. As I mentioned last week, there is still…
ContinueAdded by Pat Furlong on November 30, 2015 at 3:00pm — No Comments
Dear Friends,
It has been an incredibly intense few months as we hit the homestretch of 2015 and head into a promising 2016. One Advisory Committee meeting is down and we have another quickly approaching most likely in late January 2016.…
ContinueAdded by Pat Furlong on November 26, 2015 at 10:00am — 2 Comments
I have never been so proud of this community. Today our community reached a historic milestone, a moment I wondered if we would ever see. Today’s FDA Advisory Committee (Ad Comm) for BioMarin’s drisapersen, gave us an up close look at the regulatory process, learning firsthand what the…
ContinueAdded by Pat Furlong on November 24, 2015 at 8:30pm — 2 Comments
Tomorrow, November 24, 2015, is a historic day for the Duchenne community as we enter into our first Advisory Committee Meeting with the FDA. While some of you may be attending in person or even participating, we know that many of you are curious as to how the process will unfold throughout the day.
Watch a…
ContinueAdded by PPMD on November 23, 2015 at 2:00pm — No Comments
Dr. Stu Peltz from PTC Therapeutics shares his gratitude to the Duchenne community for the contribution families have made to the development of their therapy, Translarna.
Read Dr. Peltz's letter:
ContinueYou Are…
Added by PPMD on November 18, 2015 at 3:00pm — No Comments
For those of us who’ve been in this community for decades, at some point we began to believe that we’d never see the day when products that had been designed specifically with the intent to treat individuals with Duchenne would be reviewed by the FDA. But here we are—standing on the shoulders of the…
ContinueAdded by Annie Kennedy on November 18, 2015 at 11:00am — No Comments
By now, you probably know what to expect from the upcoming Advisory Committee meetings in terms of logistics: how to submit written testimony, how to apply for an open public hearing slot, order of the day, etc. (read what an Ad Comm is or …
ContinueAdded by PPMD on November 17, 2015 at 1:00pm — No Comments
For over a year, PPMD has been working with congressional champions and industry partners to help lead an effort to streamlining the regulatory pathways and review processes for targeted therapeutics (which would include such things as 'follow on exons') by clarifying the FDA’s existing authority to leverage data previously used in the approval of a targeted…
Continue We have a running joke in our family that Alex and I argue like an old married couple. No offense intended to those who can identify, but we do, and more often than I care to admit. Sometimes our discussions (as we call them) are silly, and sometimes they have merit. Sometimes the exchanges are brief, and sometimes a bit extended. But, what do you expect when two…
Added by Dave Click on November 4, 2015 at 1:09pm — No Comments
Many of you have seen – and signed – a petition that circulated recently about preventing Medicare from applying competitive bidding prices to complex technology; an action that will likely reduce access to wheelchair features many of our family members depend on. This effort has now evolved into a legislative effort and we urge all members of our…
ContinueAdded by Annie Kennedy on November 3, 2015 at 10:00am — No Comments
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
© 2021 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service